Compare MED & BHST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MED | BHST |
|---|---|---|
| Founded | 1980 | 2007 |
| Country | United States | Canada |
| Employees | N/A | 87 |
| Industry | Packaged Foods | |
| Sector | Consumer Staples | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 97.7M |
| IPO Year | 1996 | N/A |
| Metric | MED | BHST |
|---|---|---|
| Price | $10.22 | $4.31 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $12.00 | $12.00 |
| AVG Volume (30 Days) | ★ 262.1K | 23.2K |
| Earning Date | 04-27-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $934,842,000.00 | N/A |
| Revenue This Year | N/A | $146.27 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.22 | $4.10 |
| 52 Week High | $15.37 | $12.80 |
| Indicator | MED | BHST |
|---|---|---|
| Relative Strength Index (RSI) | 49.03 | 45.07 |
| Support Level | $9.34 | $4.27 |
| Resistance Level | $10.30 | $5.02 |
| Average True Range (ATR) | 0.34 | 0.14 |
| MACD | 0.08 | 0.02 |
| Stochastic Oscillator | 65.47 | 11.69 |
Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.
BioHarvest Sciences Inc is the developer and owner of the patented bio-cell growth platform farming technology. This company is the industrial large-scale plant cell growth technology capable of directly and constantly producing active plant ingredients without the necessity to grow the plant itself. The company is focused on leveraging its botanical synthesis technology to develop the next generation of science-based and clinical therapeutic solutions, within two business verticals - nutraceutical health and wellness products such as dietary supplements, and the development of plant cell-based Active Pharmaceutical Ingredients (APIs) that focus on specific medical indications.